TPX2 and hepatocellular carcinoma: In conclusion, our results reveal that TPX2 lactylation promotes HCC progression by disrupting the interaction between AURKA and PP1 to facilitate AURKA activation and cell cycle progression, suggesting that targeting the lactate/TPX2 lactylation/AURKA axis may be a promising strategy for development of HCC interventions.